- Abstract:
-
OBJECTIVE: The objective was to measure the efficacy of the vaccination regimen FFM ME-TRAP in preventing episodes of clinical malaria among children in a malaria endemic area. FFM ME-TRAP is sequential immunisation with two attenuated poxvirus vectors (FP9 and modified vaccinia virus Ankara), which both deliver the pre-erythrocytic malaria antigen construct multiple epitope-thrombospondin-related adhesion protein (ME-TRAP). DESIGN: The trial was randomised and double-blinded. SETTING: The s...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Publisher's Version
- Publisher:
- Public Library of Science Publisher's website
- Journal:
- PLoS Clinical Trials Journal website
- Volume:
- 1
- Issue:
- 6
- Pages:
- e29
- Publication date:
- 2006-10-20
- Acceptance date:
- 2006-09-01
- DOI:
- EISSN:
-
1555-5887
- ISSN:
-
1555-5887
- URN:
-
uuid:9f5112d0-733e-4026-a2f6-5e153120554d
- Source identifiers:
-
40290
- Local pid:
- pubs:40290
- Language:
- English
- Keywords:
- Copyright holder:
- Bejon et al.
- Copyright date:
- 2006
- Notes:
- © 2006 Bejon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Journal article
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record